In our patients, higher aTreg percentages among FOXP3+CD4+ T cells at the start of therapy were associated with a disease course characterised by more frequent serious infections during the follow-up with our patients with CLL. Here, CD4 is linked to B-cell chronic lymphocytic leukemia.